(2-ethyl-1-oxobutoxy)methyl(5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[[(1R,3S)-tetrahydro-1-oxido-3-thienyl]thio]-4-thia-1-azabicyclo[3.2.0]hept-2-carboxylate.

PK140618AUndetermined Publication Date: 2010-04-08PFIZER PROD INC
0 Cites 0 Cited by

Patent Information

Application Number
PK200700757
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Publication Date
2010-04-08
Patent Text Reader

Abstract

Orally biovaliable prodrug of sulopenem compound of the formula: and formulation thereof, use to treat and prevent infection in mammals such as humans.
Need to check novelty before this filing date? Find Prior Art